Erratum to: 18F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin’s lymphoma as predictors of treatment outcome and survival (Annals of Nuclear Medicine, (2018), 32, 6, (410-416), 10.1007/s12149-018-1260-1)

Aatif Parvez; Noam Tau; Douglas Hussey; Manjula Maganti; Ur Metser

doi:10.1007/s12149-018-1271-y

Erratum to: 18F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin’s lymphoma as predictors of treatment outcome and survival (Annals of Nuclear Medicine, (2018), 32, 6, (410-416), 10.1007/s12149-018-1260-1)

Aatif Parvez, Noam Tau, Douglas Hussey, Manjula Maganti, Ur Metser^*

^*Corresponding author for this work

Princess Margaret Hospital

Research output: Contribution to journal › Comment/debate

2 Scopus citations

Abstract

In the original publication of the article, the title was incorrectly.

Original language	English
Pages (from-to)	417
Number of pages	1
Journal	Annals of Nuclear Medicine
Volume	32
Issue number	6
DOIs	https://doi.org/10.1007/s12149-018-1271-y
State	Published - 1 Jul 2018
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s12149-018-1271-y

Fingerprint

Dive into the research topics of 'Erratum to: 18F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin’s lymphoma as predictors of treatment outcome and survival (Annals of Nuclear Medicine, (2018), 32, 6, (410-416), 10.1007/s12149-018-1260-1)'. Together they form a unique fingerprint.

Cite this

Parvez, A., Tau, N., Hussey, D., Maganti, M., & Metser, U. (2018). Erratum to: 18F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin’s lymphoma as predictors of treatment outcome and survival (Annals of Nuclear Medicine, (2018), 32, 6, (410-416), 10.1007/s12149-018-1260-1). Annals of Nuclear Medicine, 32(6), 417. https://doi.org/10.1007/s12149-018-1271-y

@article{aa5a584574f749d9888562e18a8689e9,

title = "Erratum to: 18F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin{\textquoteright}s lymphoma as predictors of treatment outcome and survival (Annals of Nuclear Medicine, (2018), 32, 6, (410-416), 10.1007/s12149-018-1260-1)",

abstract = "In the original publication of the article, the title was incorrectly.",

author = "Aatif Parvez and Noam Tau and Douglas Hussey and Manjula Maganti and Ur Metser",

note = "Publisher Copyright: {\textcopyright} 2018, The Japanese Society of Nuclear Medicine.",

year = "2018",

month = jul,

day = "1",

doi = "10.1007/s12149-018-1271-y",

language = "אנגלית",

volume = "32",

pages = "417",

journal = "Annals of Nuclear Medicine",

issn = "0914-7187",

publisher = "Springer Japan",

number = "6",

}

Parvez, A, Tau, N, Hussey, D, Maganti, M & Metser, U 2018, 'Erratum to: 18F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin’s lymphoma as predictors of treatment outcome and survival (Annals of Nuclear Medicine, (2018), 32, 6, (410-416), 10.1007/s12149-018-1260-1)', Annals of Nuclear Medicine, vol. 32, no. 6, pp. 417. https://doi.org/10.1007/s12149-018-1271-y

Erratum to: 18F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin’s lymphoma as predictors of treatment outcome and survival (Annals of Nuclear Medicine, (2018), 32, 6, (410-416), 10.1007/s12149-018-1260-1). / Parvez, Aatif; Tau, Noam; Hussey, Douglas et al.
In: Annals of Nuclear Medicine, Vol. 32, No. 6, 01.07.2018, p. 417.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum to

T2 - 18F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin’s lymphoma as predictors of treatment outcome and survival (Annals of Nuclear Medicine, (2018), 32, 6, (410-416), 10.1007/s12149-018-1260-1)

AU - Parvez, Aatif

AU - Tau, Noam

AU - Hussey, Douglas

AU - Maganti, Manjula

AU - Metser, Ur

PY - 2018/7/1

Y1 - 2018/7/1

N2 - In the original publication of the article, the title was incorrectly.

AB - In the original publication of the article, the title was incorrectly.

UR - http://www.scopus.com/inward/record.url?scp=85048830095&partnerID=8YFLogxK

U2 - 10.1007/s12149-018-1271-y

DO - 10.1007/s12149-018-1271-y

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 29926343

AN - SCOPUS:85048830095

SN - 0914-7187

VL - 32

SP - 417

JO - Annals of Nuclear Medicine

JF - Annals of Nuclear Medicine

IS - 6

ER -

Parvez A, Tau N, Hussey D, Maganti M, Metser U. Erratum to: 18F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin’s lymphoma as predictors of treatment outcome and survival (Annals of Nuclear Medicine, (2018), 32, 6, (410-416), 10.1007/s12149-018-1260-1). Annals of Nuclear Medicine. 2018 Jul 1;32(6):417. doi: 10.1007/s12149-018-1271-y

Erratum to: 18F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin’s lymphoma as predictors of treatment outcome and survival (Annals of Nuclear Medicine, (2018), 32, 6, (410-416), 10.1007/s12149-018-1260-1)

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this